Advanced search
Publication Cover
Substance Abuse Volume 43, 2022 - Issue 1
Journal homepage
106
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Assessing clinical impacts and attitudes related to COVID-19 among residential substance use disorder patients

Jared Wildbergera Mountain Manor Treatment Center, Baltimore, Maryland, USACorrespondence[email protected]
, MA,
Kevin Wenzela Mountain Manor Treatment Center, Baltimore, Maryland, USA
, PhD &
Marc Fishmana Mountain Manor Treatment Center, Baltimore, Maryland, USA;b Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
, MD
Pages 756-762 | Published online: 03 Feb 2022

References

  • Centers for Disease Control and Prevention National Center for Health Statistics. Household pulse survey. https://www.cdc.gov/nchs/covid19/pulse/mental-health.htm. Accessed October 16, 2020.
  • Centers for Disease Control and Prevention National Center for Health Statistics.Early release of selected mental health estimates based on data from the January–June 2019 National Health Interview Survey. https://www.cdc.gov/nchs/data/nhis/earlyrelease/ERmentalhealth-508.pdf. Accessed October 16, 2020.
  • Czeisler MÉ, Lane RI, Petrosky E, et al. Mental health, substance use, and suicidal ideation during the COVID-19 pandemic – United States, June 24-30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(32):1049–1057.
  • Volkow ND. Collision of the COVID-19 and addiction epidemics. Ann Intern Med. 2020;173(1):61–62.
  • Wei Y, Shah R. Substance use disorder in the COVID-19 pandemic: A systematic review of vulnerabilities and complications. Pharmaceuticals. 2020;13(7):155.
  • Wang QQ, Kaelber DC, Xu R, Volkow ND. COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States. Mol Psychiatry. 2021;26:30–39.
  • Slavova S, Rock P, Bush HM, Quesinberry D, Walsh SL. Signal of increased opioid overdose during COVID-19 from emergency medical services data. Drug Alcohol Depend. 2020;214:108176.
  • Uscher-Pines L, Sousa J, Raja P, Mehrotra A, Barnett M, Huskamp HA. Treatment of opioid use disorder during COVID-19: experiences of clinicians transitioning to telemedicine. J Subst Abuse Treat. 2020;118:108124.
  • Substance Abuse and Mental Health Services Administration. Receipt of services for substance use and mental health issues among adults: results from the 2016 National Survey on Drug Use and Health. https://www.samhsa.gov/data/sites/default/files/NSDUH-DR-FFR2-2016/NSDUH-DR-FFR2-2016.htm.
  • Yancy CW. COVID-19 and African Americans. JAMA. 2020;323(19):1891–1892.
  • Muñoz-Price LS, Nattinger AB, Rivera F, et al. Racial disparities in incidence and outcomes among patients with COVID-19. JAMA Netw Open. 2020;3(9):e2021892.
  • Alexander GC, Stoller KB, Haffajee RL, Saloner B. An epidemic in the midst of a pandemic: opioid use disorder and COVID-19. Ann Intern Med. 2020; 173(1):57–58.
  • Becker WC, Fiellin DA. When epidemics collide: coronavirus disease 2019 (COVID-19) and the opioid crisis. Ann Intern Med. 2020;173(1):59–60.
  • Green TC, Bratberg J, Finnell DS. Opioid use disorder and the COVID 19 pandemic: a call to sustain regulatory easements and further expand access to treatment. SubstAbus. 2020;41(2):147–149.
  • Samuels EA, Clark SA, Wunsch C, et al. Innovation during COVID-19: improving addiction treatment access. J Addict Med. 2020;14(4):e8–e9.
  • Vecchio S, Ramella R, Drago A, Carraro D, Littlewood R, Somaini L. COVID19 pandemic and people with opioid use disorder: innovation to reduce risk. Psychiatry Res. 2020;289:113047
  • Wenzel K, Fishman M. Mobile van delivery of extended-release buprenorphine and extended-release naltrexone for youth with OUD: an adaptation to the COVID-19 emergency. Journal of Subst Abuse Treat. 2021;120:108149.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.